Amyloid-beta peptide is central to the pathology of Alzheimer's diseas
e, because it is neurotoxic-directly by inducing oxidant stress, and i
ndirectly by activating microglia. A specific cell-surface acceptor si
te that could focus its effects on target cells has been postulated bu
t not identified. Here we present evidence that the receptor for advan
ced glycation end products' (RAGE) is such a receptor, and that it med
iates effects of the peptide on neurons and microglia. increased expre
ssion of RAGE in Alzheimer's disease brain indicates that it is releva
nt to the pathogenesis of neuronal dysfunction and death.